143 related articles for article (PubMed ID: 6215831)
1. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
Aberg-Wistedt A
Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
[TBL] [Abstract][Full Text] [Related]
2. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
Aberg-Wistedt A
Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
[TBL] [Abstract][Full Text] [Related]
3. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
[TBL] [Abstract][Full Text] [Related]
4. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
Aberg A
Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
[TBL] [Abstract][Full Text] [Related]
5. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of zimelidine and desipramine in endogenous depression.
Lingjaerde O; Bratfos O; Bratlid T; Haug JO
Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
[TBL] [Abstract][Full Text] [Related]
7. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
[TBL] [Abstract][Full Text] [Related]
8. Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
Potter WZ; Calil HM; Extein I; Muscettola G; Goodwin FK
Psychopharmacol Bull; 1981 Jan; 17(1):26-9. PubMed ID: 6453356
[No Abstract] [Full Text] [Related]
9. Zimelidine: a placebo-controlled trial in depression.
Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
Syvälahti E; Salminen J; Lehtinen V
J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
[TBL] [Abstract][Full Text] [Related]
11. An open trial of zimelidine in patients with endogenous depression.
Kiloh LG; Moore G
Int Pharmacopsychiatry; 1982; 17(1):28-35. PubMed ID: 6211416
[TBL] [Abstract][Full Text] [Related]
12. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
Montgomery SA; McAuley R; Rani SJ; Roy D; Montgomery DB
Acta Psychiatr Scand Suppl; 1981; 290():314-27. PubMed ID: 6452798
[TBL] [Abstract][Full Text] [Related]
13. Effects of antidepressant treatments on dopamine turnover in depressed patients.
Linnoila M; Karoum F; Potter WZ
Arch Gen Psychiatry; 1983 Sep; 40(9):1015-7. PubMed ID: 6225405
[TBL] [Abstract][Full Text] [Related]
14. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
[TBL] [Abstract][Full Text] [Related]
15. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
[No Abstract] [Full Text] [Related]
16. Comparative pharmacokinetics of zimelidine and desipramine in man following acute and chronic administration.
Potter WZ; Calil HM; Extein I; Zavadil AP; Goodwin FK
Psychiatry Res; 1979 Dec; 1(3):273-81. PubMed ID: 298355
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
Georgotas A; Krakowski M; Gershon S
Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
[TBL] [Abstract][Full Text] [Related]
18. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
[TBL] [Abstract][Full Text] [Related]
19. Zimelidine vs maprotiline in depressed outpatients. A preliminary report.
d'Elia G; Hällström T; Nyström C; Ottosson JO
Acta Psychiatr Scand Suppl; 1981; 290():225-35. PubMed ID: 6452793
[TBL] [Abstract][Full Text] [Related]
20. Zimelidine: comparison of different dosage regimes in general practice.
Watson JM; Tiplady B
Acta Psychiatr Scand Suppl; 1981; 290():464-70. PubMed ID: 6452806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
